Purchase Order 36C26025P0979
Award Date
7/1/25
Potential Completion Date
9/30/25
Potential Value
$40K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Accredo Health Group, Inc. for $307,946.88 was made on June 28, 2024 by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 20 (VISN 20). The contract is for the delivery of LUMRYZ 9GM/PKT (SODIUM OXYBATE 9GM/PKT GRNL,ECORAL) 30CT, a specialty pharmaceutical product utilized in VA treatment programs. As the prime contractor, Accredo Health Group will provide this medication directly to VA medical centers nationwide through a firm...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of LUMRYZ (sodium oxybate) 6 GM/PKT, a specialty pharmaceutical product, to the VA's Veterans Integrated Service Network 9. The contract has a ceiling value of $12,222.02 and a period of performance ending on June 30, 2025. The contract was awarded on June 4, 2025, and does not have...
This is a firm fixed-price purchase order award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmaceutical distribution company. The $38,493.36 contract is for the delivery of LUMRYZ 9GM/PKT (sodium oxybate), a specialty medication, to support the VHA's integrated healthcare networks. As a prime contractor, Accredo regularly fulfills purchase orders and multi-year contracts with the VA to supply specialty...
This federal contract award, valued at $80,409.58, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company and subsidiary of Express Scripts. The contract is a firm fixed-price purchase order for the delivery of 9 pharmacy orders across multiple VISN locations, including medications to treat conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA), to Accredo Health Group, Inc., a for-profit pharmaceutical company based in Memphis, Tennessee. The contract is for the provision of DUOPA medication, an emergency pharmaceutical product, with a ceiling value of $10,122.32 and a period of performance ending on September 30, 2025. The contract does not utilize any set-aside...
Accredo Health Group, Inc. was awarded a firm fixed price purchase order without set aside designation from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6. The contract has a potential value of $154,457.60 and a completion date of January 23, 2024. As the prime contractor, Accredo Health Group will provide OXERVATE medicine to the VA medical center located in Bartlett, Tennessee. As a pharmacy benefit management company specializing in...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical DUOPA. The $10,122.32 contract has a completion date of May 7, 2025 and was awarded on February 7, 2025 with no set-aside designation. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily...
This federal contract award, with the ID VA25917E0551, was issued by the Department of Veterans Affairs (VA) to the prime contractor Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The award consists of 13 firm fixed-price purchase orders totaling $108,039.41, with an ultimate completion date of September 30, 2016. The contract does not have a set-aside designation. Accredo Health Group, Inc. has been a long-standing...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...